Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ZSP 1601

Next Previous
Drug Profile

ZSP 1601

Alternative Names: ZSP-1601

Latest Information Update: 20 Jun 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Guangdong Zhongsheng Pharmaceutical
  • Developer Guangdong Raynovent Biotech; Guangdong Zhongsheng Pharmaceutical
  • Class Hepatoprotectants; Small molecules
  • Mechanism of Action Type 2 cyclic nucleotide phosphodiesterase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Non-alcoholic steatohepatitis

Most Recent Events

  • 03 Jun 2023 Phase-II clinical trials in Non-alcoholic steatohepatitis in China (PO) (NCT05692492)
  • 20 Jan 2023 Guangdong Raynovent Biotech plans a phase II trial for Non-alcoholic steatohepatitis (In adults, In the elderly) in China (PO, Tablet) in February 2023(NCT05692492)
  • 22 Jun 2022 Efficacy, adverse events and pharmacokinetics data from a phase I/II trial in Non-alcoholic steatohepatitis presented at the International Liver Congress 2022 (ILC-2022)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top